European Journal of Medicinal Chemistry

Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies
pp. 463-480(18)
Authors: Dal Piaz V.; Giovannoni M.P.

Palladium(II) complexes of NS donor ligandsderived from S-methyl-dithiocarbazate, S-benzyldithiocarbazateand thiosemicarbazide as antiamoebic agents
pp. 481-486(6)
Authors: Neelam B.; Mannar R. M.; Fehmida N.; Alok B.; Sudha B.; Amir A.

Growth hormone secretagogues derived from NN703 with hydrazidesas c-terminal
pp. 487-497(11)
Authors: Ankersen M.; Kramer Nielsen K.; Kruse Hansen T.; Raun K.; Sehested Hansen B.

The pyrrole moiety as a template for COX-1/COX-2 inhibitors
pp. 499-510(12)
Authors: Dannhardt G.; Kiefer W.; Kramer G.; Maehrlein S.; Nowe U.; Fiebich B.

Spirostanols obtained by cyclization of pseudosaponin derivatives and comparison of anti-platelet agglutination activities of spirostanol glycosides
pp. 511-527(17)
Authors: Tobari A.; Teshima M.; Koyanagi J.; Kawase M.; Miyamae H.; Yoza K.; Takasaki A.; Nagamura Y.; Saito S.

New -fluoromethotrexates modified in the pteridine ring: synthesis and in vitro immunosuppressive activity
pp. 529-534(6)
Authors: Kokuryo Y.; Nakatani T.; Kakinuma M.; Kabaki M.; Kawata K.; Kugimiya A.; Kawada K.; Matsumoto M.; Suzuki R.; Ohtani M.

Synthesis and antitubercular activity of 3-aryl substituted-2-(1H(2H)benzotriazol-1(2)-yl)acrylonitriles^#
pp. 535-543(9)
Authors: Sanna P.; Carta A.; Nikookar M.E.R.

Synthesis and antitumour activity of 4-hydroxy-2-pyridone derivatives
pp. 545-552(8)
Authors: Cocco M.T.; Congiu C.; Onnis V.